Skip to main content
. Author manuscript; available in PMC: 2011 May 4.
Published in final edited form as: Semin Ophthalmol. 2011 Jan;26(1):28–32. doi: 10.3109/08820538.2010.541317

TABLE 1.

Characteristics of the study group.*

Variable Normal
subjects
(n = 53)
OHT
(n = 69)
POAG subjects
(n = 186)
P-value
Age, years
< 65 17 (32.1) 22 (32.9) 29 (15.6) <0.0001
65–74 17 (32.1) 33 (47.8) 68 (36.6)
75+ 19 (35.9) 14 (20.3) 89 (47.9)
Sex
Female 38 (71.7) 44 (63.8) 107 (57.5) 0.156
Male 15 (28.3) 36 (36.2) 79 (42.5)
CCT, microns
> 515 45 (84.9) 58 (84.1) 126 (67.7) <0.0001
≤ 515   8 (15.1) 11 (15.9) 60 (32.3)
HBP (by History)
No 39 (73.6) 29 (42.0) 92 (49.5) 0.001
Yes 14 (26.4) 40 (58.0) 94 (50.5)
DM (by History)
No 39 (73.6) 54 (78.3) 140 (75.3) 0.822
Yes 14 (26.4) 15 (21.7) 46 (24.7)
VF stage
0–2 53 (100.0) 69 (100.0) 127 (68.3) <0.0001§
3–5   0   0 59 (31.7)
*

Values are number of subjects (percentages) unless otherwise indicated.

OHT: Ocular Hypertension; POAG: Primary Open Angle Glaucoma; HBP: Hypertension; DM: Diabetes Mellitus; VF stage: Visual Field stage.

p<0.05-Pearson’s chi square;

§

p<0.05-Fisher’s exact test.